AbbVie Inc.
ABBV · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $410,288,880 | $328,918,640 | $370,431,360 | $314,351,300 |
| - Cash | $5,629,000 | $6,467,000 | $5,175,000 | $5,524,000 |
| + Debt | $68,743,000 | $70,481,000 | $69,889,000 | $67,841,000 |
| Enterprise Value | $473,402,880 | $392,932,640 | $435,145,360 | $376,668,300 |
| Revenue | $15,776,000 | $15,423,000 | $13,343,000 | $15,102,000 |
| % Growth | 2.3% | 15.6% | -11.6% | – |
| Gross Profit | $12,386,000 | $13,020,000 | $9,341,000 | $10,706,000 |
| % Margin | 78.5% | 84.4% | 70% | 70.9% |
| EBITDA | $3,444,000 | $4,344,000 | $4,400,000 | $535,000 |
| % Margin | 21.8% | 28.2% | 33% | 3.5% |
| Net Income | $186,000 | $944,000 | $1,286,000 | -$22,000 |
| % Margin | 1.2% | 6.1% | 9.6% | -0.1% |
| EPS Diluted | 0.1 | 0.53 | 0.72 | -0.018 |
| % Growth | -81.1% | -26.4% | 4,077.9% | – |
| Operating Cash Flow | $7,024,000 | $5,153,000 | $1,635,000 | $7,048,000 |
| Capital Expenditures | $504,000 | -$269,000 | -$235,000 | -$291,000 |
| Free Cash Flow | $7,528,000 | $4,884,000 | $1,400,000 | $6,757,000 |